Genetic and Clinical Characteristics of Central Serous Chorioretinopathy With Steroid Use

Seigo Yoneyama; Ayumi Fukui; Yoichi Sakurada; Nobuhiro Terao; Natsuki Kusada; Wataru Kikushima; Yumi Kotoda; Fumihiko Mabuchi; Chie Sotozono; Kenji Kashiwagi

doi:10.7759/cureus.58631

Genetic and Clinical Characteristics of Central Serous Chorioretinopathy With Steroid Use

Cureus. 2024 Apr 20;16(4):e58631. doi: 10.7759/cureus.58631. eCollection 2024 Apr.

Affiliations

¹ Department of Ophthalmology, University of Yamanashi, Yamanashi, JPN.
² Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, JPN.

Abstract

Purpose: To compare the genetic and clinical characteristics of central serous chorioretinopathy (CSC) in patients with and without steroid use.

Methods: A total of 407 consecutive patients with CSC were included. Demographic data and clinical factors, including subfoveal choroidal thickness, bilateral involvement, descending tracts, pachydrusen, fibrin, and dome-shaped pigment epithelial detachment, were obtained. Variants of complement factor H (CFH) I62V (rs800292) and rs1329428 were genotyped in all cases using TaqMan technology.

Results: Of the total patients, 48 (11.8%) were steroid users. The majority of males were non-steroid users (82.5%) than steroid users (58.3%) (p = 9.8 × 10^-5). Demographic data and the prevalence of clinical factors were comparable between the two groups (all p-values > 0.10). Risk allele frequencies of CFH rs800292 and rs1329428 were also comparable between the two groups (p = 0.76, rs800292: steroid users = 52.1% vs. non-steroid users = 50.4%; p = 0.62, rs1329428: steroid users = 47.9% vs. non-steroid users = 45.3%).

Conclusions: Except for the male/female ratio, there were no significant differences in the clinical presentation or genetic characteristics, including variants of the CFH gene, between the two groups.

Keywords: central serous chorioretinopathy; clinical characteristics; complement factor h; gender; steroid use.